We also studied their correlation with clinicopathological factors and the possibility of using CXCR-4/CD133 as well as CXCR-4/PKC-δ double positivity to predict poor prognosis in oral cancer. This evidence concerns the gene PROM1 and lip and oral cavity carcinoma.